Sanger Sequencing Service Market Size, Trends and Growth Analysis by 2027

The global market for Sanger sequencing services is projected to grow significantly, reaching an estimated US$ 1,360.47 million by 2027, up from US$ 489.43 million in 2018. This growth represents a compound annual growth rate (CAGR) of 12.2% from 2019 to 2027.

Several factors are propelling the expansion of the Sanger sequencing service market. One of the primary drivers is the increasing number of providers offering Sanger sequencing services, alongside the expanding range of applications for this technology. However, the market's growth may be somewhat constrained by a shortage of skilled professionals in the field.

Sanger sequencing is a technique that necessitates a high level of expertise to ensure accurate results, which are crucial for various applications including diagnostics, personalized medicine, and biomarker identification, all of which must adhere to both national and international regulatory standards. Consequently, laboratories engaged in Sanger sequencing must employ highly qualified and trained scientific personnel. Unfortunately, these laboratories often encounter challenges in recruiting individuals with the necessary experience and training, which can lead to inaccuracies in results due to insufficient training.

Moreover, the rising number of genome editing studies further emphasizes the need for skilled professionals to effectively manage these projects. According to data from the Bureau of Labor Statistics (BLS), there were approximately 335,700 medical and clinical laboratory technologists and technicians employed in the United States as of 2016. The BLS has projected a 13% increase in the demand for medical laboratory technologists and technicians from 2016 to 2026. This anticipated shortfall in skilled professionals is likely to pose a challenge to the growth of the Sanger sequencing service market.

The global Sanger sequencing service market can be segmented based on application and end-user categories. In terms of application, the market is divided into several key areas: diagnostics, biomarkers and cancer research, reproductive health, personalized medicine, forensics, and other specialized applications. On the other hand, the market is also classified according to end users, which include academic and government research institutions, biotechnology and pharmaceutical companies, hospitals and clinics, as well as other relevant entities.

To compile the insights presented in this report, a variety of primary and secondary sources were consulted. Notable references include the Japan Medical and Research Development Agency, the World Health Organization, the Dubai Genetics Center, the National Institute of Genomic Medicine, and the National Institutes of Health, among others.

In summary, while the Sanger sequencing service market is on a robust growth trajectory, driven by increasing service providers and diverse applications, it faces challenges related to the availability of skilled professionals. Addressing this skills gap will be crucial for sustaining the market's growth and ensuring the accuracy and reliability of sequencing results.